Evolution and Impact of Hepatitis A Epidemiology in Europe—Systematic Literature Review of the Last 20 Years
2024

Hepatitis A Epidemiology in Europe: A 20-Year Review

Sample size: 43 publication Evidence: moderate

Author Information

Author(s): Andani Anar, Mellou Kassiani, Dewda Pavitra, Eeuwijk Jennifer, Kassianos George, Van Damme Pierre, Steffen Robert

Primary Institution: GSK Wavre Belgium

Hypothesis

What are the current epidemiological characteristics and severity of hepatitis A disease in Europe over the past two decades?

Conclusion

The study found that hospitalization rates for hepatitis A varied significantly across European countries, highlighting the need for improved awareness and prevention strategies.

Supporting Evidence

  • Hepatitis A infections affect 150 million people globally each year.
  • Hospitalization rates for hepatitis A varied from ≤32% in the Netherlands to ≥81% in Greece.
  • Case fatality rates for hepatitis A were low, ranging from 0.03% to 0.26%.
  • Continuous monitoring of epidemiological data is crucial for effective prevention strategies.

Takeaway

Hepatitis A is still a problem in Europe, especially for adults who haven't been exposed to it before, and many people end up in the hospital because of it.

Methodology

A systematic literature review was conducted using PubMed and Embase to assess hepatitis A disease outcomes in 11 European countries from 2001 to 2021.

Potential Biases

Selection of countries based on HAV endemicity may have introduced bias.

Limitations

Data on hospitalization rates and complications may not provide a complete overview due to underreporting and differences in healthcare systems across countries.

Participant Demographics

The review included data from 11 European countries with varying endemicity and vaccination strategies.

Digital Object Identifier (DOI)

10.1111/jvh.14030

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication